Christopher K. Murray, CHIEF TECHNICAL OPERATIONS at Blueprint Medicines Corp (BPMC), sold 5,000 shares at $75.00 ($375K) on 2023-12-07, disclosed to the SEC on 2023-12-11.
Open-market sale of $375k BPMC by CHIEF TECHNICAL OPERATIONS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BPMC | SELL | 2024-03-01 | $500K | — | Filing → |
| BPMC | SELL | 2023-12-06 | $43K | — | Filing → |
| BPMC | SELL | 2023-10-30 | $34K | — | Filing → |